We found eight proteins (ITGA2B, ITGB3, VWF, PLEK, TNF, TLR2, BCL2 and BCL2L1) were the core targets of DMAG for the treatment of thrombocytopenia. Here, BCL2L1 is linked to Thrombocytopenia.